Therapy (HCV)

Second Round of IFN Therapy Effective for Some Relapse Patients

Published in Hepatitis Weekly, December 15th, 1997

Chronic hepatitis C patients who relapse after complete response to interferon (IFN)-(alpha) therapy can be retreated with IFN-(alpha) alone for one year, according to results of a study from Italy.

Nonresponders, however, will need an alternative therapy or IFN-(alpha) combined with other treatment to obtain a sustained response.

A majority of hepatitis C patients do not maintain a sustained response to IFN therapy. To determine if retreatment of transient or nonresponders with recombinant IFN-(alpha) alone was effective, Liliana Chemello of the University of Padova and colleagues treated 92 such chronic hepatitis C virus (HCV) patients with...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (1997-12-15)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry